XTX Markets’s Amneal Pharmaceuticals AMRX Stock Holding History

XTX Markets’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-10,243	Closed	-$40K	–	195
2020 Q3	$40K	Buy	+10,243	New	+$43.8K	0.19%	90

Other funds holding AMRX

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

XTX Markets's AMRX Position: Q4 2020 in Review

XTX Markets sold out of Amneal Pharmaceuticals (AMRX) in Q4 2020, closing a stake of 10,243 shares — an estimated $40K sold.

XTX Markets first reported a position in AMRX in Q3 2020 and held it in 1 quarter. The position peaked at $40K in Q3 2020. 133 funds tracked by Wall St. Rank hold AMRX as of Q4 2020.

XTX Markets reported no remaining Amneal Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
XTX Markets sold 10,243 Amneal Pharmaceuticals shares in Q4 2020, an estimated $40K.
XTX Markets first reported a position in Amneal Pharmaceuticals in Q3 2020 and held it in 1 quarter.
XTX Markets's Amneal Pharmaceuticals position peaked at $40K in Q3 2020.
133 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2020.

Based on XTX Markets's 13F filing for Q4 2020, filed 25 Jan 2021.